Product Code: ETC417497 | Publication Date: Oct 2022 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The corticosteroids market in China is experiencing growth driven by the increasing prevalence of chronic inflammatory conditions such as asthma, rheumatoid arthritis, and psoriasis. The rise in healthcare expenditure and awareness about corticosteroids` benefits contribute to this growth. Additionally, advancements in pharmaceutical research and development are expanding the range of corticosteroid products available, further fueling market expansion. However, regulatory challenges and concerns about the long-term use of corticosteroids, including potential side effects, pose significant hurdles.
The China corticosteroids market is propelled by the increasing prevalence of chronic inflammatory diseases and autoimmune disorders, such as rheumatoid arthritis and asthma. Enhanced awareness and advancements in medical technology have led to a growing demand for corticosteroids, which are essential in managing these conditions. Furthermore, the rise in geriatric populations who are more susceptible to these diseases has also driven market growth. Additionally, the expanding pharmaceutical sector in China, supported by government initiatives and investments, contributes to the development and accessibility of new corticosteroid formulations.
The China corticosteroids market faces significant challenges primarily due to regulatory scrutiny and competition. Stringent regulations on the manufacturing and distribution of corticosteroids impose high compliance costs on companies, affecting their profitability. Additionally, the market is highly competitive with numerous domestic and international players vying for market share, leading to pricing pressures and reduced profit margins. Counterfeit and substandard products also pose a significant risk, impacting consumer trust and safety. Furthermore, the rapid evolution of pharmaceutical standards requires continuous innovation and adaptation from companies, adding to their operational complexities.
In China, the corticosteroids market is influenced by several government policies designed to ensure drug safety and efficacy. The National Medical Products Administration (NMPA) regulates the approval and oversight of corticosteroids, enforcing stringent guidelines on manufacturing processes, clinical trials, and labeling. Policies aimed at curbing counterfeit drugs and ensuring quality control are critical in this sector. Additionally, the government has introduced price controls and reimbursement policies to make corticosteroids more affordable for patients, impacting market dynamics.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Corticosteroids Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Corticosteroids Market Revenues & Volume, 2021 & 2031F |
3.3 China Corticosteroids Market - Industry Life Cycle |
3.4 China Corticosteroids Market - Porter's Five Forces |
3.5 China Corticosteroids Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 China Corticosteroids Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Corticosteroids Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 China Corticosteroids Market Trends |
6 China Corticosteroids Market, By Types |
6.1 China Corticosteroids Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 China Corticosteroids Market Revenues & Volume, By Application, 2021-2031F |
6.1.3 China Corticosteroids Market Revenues & Volume, By Skin Allergies, 2021-2031F |
6.1.4 China Corticosteroids Market Revenues & Volume, By Rhuematology Indications, 2021-2031F |
6.1.5 China Corticosteroids Market Revenues & Volume, By Endocrinology, 2021-2031F |
6.1.6 China Corticosteroids Market Revenues & Volume, By Acute Respiratory Diseases, 2021-2031F |
6.1.7 China Corticosteroids Market Revenues & Volume, By Others, 2021-2031F |
6.2 China Corticosteroids Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 China Corticosteroids Market Revenues & Volume, By Hospitals, 2021-2031F |
6.2.3 China Corticosteroids Market Revenues & Volume, By Clinics, 2021-2031F |
6.2.4 China Corticosteroids Market Revenues & Volume, By Research Institutes, 2021-2031F |
6.2.5 China Corticosteroids Market Revenues & Volume, By Others, 2021-2031F |
7 China Corticosteroids Market Import-Export Trade Statistics |
7.1 China Corticosteroids Market Export to Major Countries |
7.2 China Corticosteroids Market Imports from Major Countries |
8 China Corticosteroids Market Key Performance Indicators |
9 China Corticosteroids Market - Opportunity Assessment |
9.1 China Corticosteroids Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 China Corticosteroids Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China Corticosteroids Market - Competitive Landscape |
10.1 China Corticosteroids Market Revenue Share, By Companies, 2024 |
10.2 China Corticosteroids Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |